Anti-squames cleansing gel

New

KELUAL DS Anti-Scaling Cleansing Gel is a daily care product indicated for the treatment of seborrheic dermatitis and pityriasis versicolor.

Thanks to a patented combination of active ingredients, it soothes redness and eliminates flaky skin, while purifying the skin.

Hygiene product used in combination with or as a relay to reference treatments for seborrheic dermatitis.

  • For whom?
    From age 12
    Adults
  • Price
  • Texture
    Creamy mousse.

Patient relations

  • Application tips

    Once a day on damp skin. Leave on for a few moments. Rinse off. Dry gently.
    Rinse in case of eye contact.

Patient information sheets
To support your patients during their treatments
Prescriptions
To save time on your medical prescriptions in combination with dermo-cosmetic care routines

Ingredients

Active ingredients:

Ciclopiroxolamine (CPO)
Actif

CPO is the most widely used non-azole antifungal agent for the treatment of seborrheic dermatitis.

Piroctone olamine (PO)
Actif

PO is an antifungal agent of the N Hydroxy pyridone family. Active ingredient with a fungicidal and fungistatic action on  yeasts.

β glycirrhenitic acid
Actif

Derived from the licorice root (Glycyrrhiza glabra), this active ingredient has significant anti-inflammatory and soothing properties.

Keluamid
Actif

Amphiphilic keratolytic active, which means that it is both hydrophilic and lipophilic.

Formula details:

WATER (AQUA)
DISODIUM LAURETH SULFOSUCCINATE
CETEARETH-60 MYRISTYL GLYCOL
LAURYL BETAINE
DECYL GLUCOSIDE
GLYCERYL LAURATE
1,2-HEXANEDIOL
CAPRYLYL GLYCOL
CICLOPIROX OLAMINE
CITRIC ACID
PIROCTONE OLAMINE
SODIUM CHLORIDE
TRISODIUM ETHYLENEDIAMINE DISUCCINATE

Click on an ingredient type to highlight it in the list

Water
Cleaner
Texturing agent
Stabilizing agent
Active ingredient
PH regulator

Clinical results and publications

Efficacy results

-61%

Squames (seborrheic dermatitis) at D7 (2)

- 66%

Skin spots (pityriasis versicolor) at D21 (3)

Tolerance results

Very good skin and eye tolerance (1)

Terms of use

Tolerance and efficacy study on 30 subjects with mild to moderate seborrheic dermatitis of the face. 1 application per day for 3 weeks.

(1) Cutaneous and ocular tolerance rated by investigators.

(2) Scaling of desquamation severity score by investigators (scale 0 to 4) at D7.

(3) Severity score of skin spots by investigators (scale 0 to 4) at D21.

Tolerance and efficacy study on 32 subjects with mild-to-moderate pityriasis versicolor of the face and/or body. 1 application per day for 3 weeks.

 

Discover the range

Filter by

All products
Treatment
Hygiene
Care
New
DU_KELUAL DS_SOOTHING-CREAM_packshot_FRONT_40ml_3282770392371
KELUAL DS
Soothing face cream
View more
DU_KELUAL_KERATOREDUCING-EMULSION_FRONT_TUBE_50ml_3282770202274
KELUAL
Kerato-reducing emulsion
View more
du_kelual ds_treatment-shampoo_severe dandruff conditions_Packshot_front_bottle_100ml_3282770140453
KELUAL DS
Treatment shampoo
View more
DU_ELUTION_GENTLE-BALANCING-SHAMPOO_FRONT_BOTTLE_200ml_3282770139099
ELUTION
Gentle rebalancing shampoo
View more

Contact us

Would you like to meet a sales representative?

Our medical sales representatives come to your workplace to answer all your questions about our brands and products.

Make an appointment

The product concerned may not be available in your country. Please contact your medical sales representative for further information.

Have you noticed any side effects?

The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!

Report an adverse reaction

Our commitments

Made in France

Manufactured in our factories in France.

Conscious Care

Pierre Fabre Laboratories brands, including Laboratoires Dermatologiques Ducray, have joined forces to create Conscious Care: a dermo-cosmetic for the future that acts consciously towards its entire ecosystem.

Supporting associations

Laboratoires Dermatologiques Ducray supports 14 patient associations around the world, with the aim of pooling information on pathologies to improve patient care.